AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Early Intervention Based on Neonatal Crawling in Very Premature Infants at Risk For Neurodevelopmental Disorder

RecruitingNAAges 39 Weeks - 42 WeeksAllMarianne Barbu-Roth
💬

In plain words

What the trial is, and whether it could suit you

Extreme prematurity is constantly increasing according to the World Health Organization. However, methods to train premature infants at risk of disability is sorely lacking. The goal of this project is to overcome this problem. In previous studies, the investigators discovered that promoting the crawling of typical newborns on a mini skateboard, the Crawliskate (a new tool that the investigators designed and patented EP2974624A1), is an excellent way to stimulate infants' motor and locomotor development. This method is a promising way to provide early interventions in infants at heightened risk for developmental delay, such as premature infants. The specific objective of this study is to determine if early training in crawling on this mini skateboard will accelerate motor (particularly locomotor) and/or neuropsychological development in very premature infants identified as high risk for

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Term between 24-26 GA or 26-32 GA with suspected brain lesion * parental consent * family living in intervention area * good tolerance on the first crawliskate trial Exclusion Criteria: * no bronchodysplasia defined by oxygen dependency after 36 GA * no medical disease * no limb deformity * no karyotype anomaly * no visual or auditory impairment
💊

What it tests

  • Crawling stimulation with a mini-skateboard (i.e. the crawliskate)
📍

Where

3 sites
Hôpital Paris Saint-Joseph
Paris, France
Cnrs Umr 8002
Paris, France
Hôpital Robert Debré
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy